drugset / Trial / NCT00157651

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

NCT00157651

Phase 3 Completed 170 enrolled Hamilton Health Sciences Corporation
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study examines whether low intensity, dose adjusted warfarin prolongs the time to mechanical failure of hemodialysis catheters without resulting in an unacceptable rate of bleeding.

Timeline

Start
1999-02
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Warfarin Small molecule Oral